# Safety Study of 2DG With Stereotactic Radiosurgery

> **NCT00247403** · PHASE1 · WITHDRAWN · sponsor: **University of Iowa**

## Conditions studied

- Intracranial Neoplasms
- Neoplasm Metastasis

## Interventions

- **DRUG:** 2-deoxyglucose (2DG)

## Key facts

- **NCT ID:** NCT00247403
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Pharmaceutical company no longer manufactures drug
- **Last updated:** 2015-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247403, "Safety Study of 2DG With Stereotactic Radiosurgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00247403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*